TickerFacts.

Rezolute, Inc. (RZLT): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$82.94M
Year ended 2026-06-30
2013-06-30: -$6.11M2014-06-30: -$5.16M2018-06-30: -$27.67M2019-06-30: -$25.89M2020-06-30: -$20.50M2021-06-30: -$22.88M2022-06-30: -$41.83M2023-06-30: -$55.96M2024-06-30: -$70.39M2025-06-30: -$79.86M2026-06-30: -$82.94M-$82.94M
2013-06-30 EBITDA (USD) 2026-06-30
Period endedEBITDAChange YoYSource filing
2026-06-30-$82.94Mn/m2026-09-24, From 2025-07-01
2025-06-30-$79.86Mn/m2026-09-24, From 2024-07-01
2024-06-30-$70.39Mn/m2025-09-17, From 2023-07-01
2023-06-30-$55.96Mn/m2024-09-19, From 2022-07-01
2022-06-30-$41.83Mn/m2023-09-14, From 2021-07-01
2021-06-30-$22.88Mn/m2022-09-15, From 2020-07-01
2020-06-30-$20.50Mn/m2021-09-15, From 2019-07-01
2019-06-30-$25.89Mn/m2020-10-13, From 2018-07-01
2018-06-30-$27.67Mn/a2019-09-10, From 2017-07-01
No annual figure between 2014-06-30 and 2018-06-30.
2014-06-30-$5.16Mn/m2015-09-28, From 2013-07-01
2013-06-30-$6.11Mn/a2014-09-30, From 2012-07-01

EBITDA at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Rezolute, Inc. (RZLT)2026-06-30-$82.94Mn/m
Milestone Pharmaceuticals Inc. (MIST)2025-12-31-$62.03Mn/m
Rafael Holdings, Inc. (RFL)2025-07-31-$28.87Mn/m
Avalo Therapeutics, Inc. (AVTX)2025-12-31-$72.58Mn/m
Aardvark Therapeutics, Inc. (AARD)2025-12-31-$62.69Mn/m
Camp4 Therapeutics Corp (CAMP)2025-12-31-$50.92Mn/m
Celularity Inc (CELU)2025-12-31-$54.01Mn/m
Aytu Biopharma, Inc (AYTU)2026-06-30-$4.38Mn/m
Minerva Neurosciences, Inc. (NERV)2025-12-31-$15.10Mn/m

Compare RZLT, MIST, RFL, AVTX side by side · Screen every company in Pharmaceutical Preparations ↗